Retiro De Equipo (Recall) de In vitro diagnostic reagents for the detection of active vitamin B12, testosterone and glycosylated hemoglobin on immunochemical analyzers ARCHITECT i

Según Federal Service for Surveillance in Healthcare, este evento ( retiro de equipo (recall) ) involucró a un dispositivo médico en Russian Federation que fue producido por Abbott Laboratories.

¿Qué es esto?

Una corrección al equipo o acción de retiro tomada por el fabricante para abordar un problema con un dispositivo médico. Los retiros (recalls) ocurren cuando un dispositivo médico está defectuoso, cuando puede poner en riesgo la salud, o cuando simultáneamente está defectuoso y puede poner en riesgo la salud.

Más información acerca de la data acá
  • Tipo de evento
    Recall
  • ID del evento
    01И-2657/16, ФСЗ 2012/13420
  • Fecha
    2016-12-23
  • Fecha de publicación del evento
    2016-12-26
  • País del evento
  • Fuente del evento
    FSSH
  • URL de la fuente del evento
  • Notas / Alertas
    Russian data is current through January 2019. All of the data comes from the Federal Service for Surveillance in Healthcare, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Russia.
  • Notas adicionales en la data
    Manufacturer Recall

Manufacturer

  • Empresa matriz del fabricante (2017)
  • Comentario del fabricante
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    FSSH
{"cc_re__cc_re__cc_by_sa_3_0": ["nsultar con sus m\u00e9dicos para determinar si la data contiene informaci\u00f3n relevante y si la misma tiene implicaciones m\u00e9dicas para ellos.\n    </p>\n  </section>\n\n    <section class=\"sidebar__section\">\n      <h3 class=\"sidebar__section__heading\">\n        Descargar la data\n      </h3>\n      <p>\n        La International Medical Devices Database est\u00e1 bajo la licencia <a href=\"http://opendatacommons.org/licenses/odbl/1.0/\" target=\"_blank\">Open Database License</a> y sus contenidos bajo la licencia  <a href=\"http://creativecommons.org/licenses/by-sa/3.0/\" target=\"_blank\">Creative Commons Attribution-ShareAlike</a> . Al usar esta data, siempre citar al  <a href=\"https://icij.org\" target=\"_blank\">International Consortium of Investigative Journalists</a>. Puede descargar ac\u00e1 una copia de la base de datos.\n      </p>\n      <a class=\"btn btn-block btn-outline-primary text-primary\" href=\"/download/icij-imddb-2023-04-11.zip\">\n        <i class=\"fa fa-download mr-2\"></i>\n        Descargar todo (zipped)\n</a>    </section>\n</aside>\n\n    </div>\n  </div>\n</div>\n\n    \n    <g"]}